Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Two commonly used GLP-1 agonists are Semaglutide and Tirzepatide
Watch the Recording What Youll Learn Current payer perspectives on GLP-1 coverage for obesity treatment and type 2 diabetes management Emerging affordability thresholds and price sensitivity among plans Strategies for addressing off-label type 2 diabetes GLP-1 use and its financial impact Approaches to prior authorization protocols and BMI requirements for obesity GLP-1s The role of weight management vendors in comprehensive obesity GLP-1 coverage strategies Market insights on compounded GLP-1 products and their place in benefit design Attendees will gain actionable strategies and insights to optimize their pharmacy benefit design for these high-impact medications in 2025 and beyond
Rose Parkway corridor, with convenient access from Henderson, Green Valley, Summerlin, and the rest of the Las Vegas Valley
Sullivan, G
US$ 28.56
US$ 28.01
US$ 25.80
US$ 24.58
US$ 22.51
US$ 24.53
US$ 29.53
US$ 25.31
US$ 25.11
US$ 21.60
US$ 27.48
